title: Acid-suppressing drugs during pregnancy.
authors.affiliation: Hospital for Sick Children, Toronto.
authors.forename: A
authors.initials: A
authors.lastname: Lalkin
authors.forename: L
authors.initials: L
authors.lastname: Magee
authors.forename: A
authors.initials: A
authors.lastname: Addis
authors.forename: R
authors.initials: R
authors.lastname: Loebstein
authors.forename: G
authors.initials: G
authors.lastname: Koren
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000897:Anti-Ulcer Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015331:Cohort Studies; D005260:Female; D005333:Fetus / Q000187:drug effects; D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D009853:Omeprazole / Q000009:adverse effects / Q000627:therapeutic use*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011256:Pregnancy Outcome; D011261:Pregnancy Trimester, First; D011446:Prospective Studies; D011899:Ranitidine / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D011899:Ranitidine; D009853:Omeprazole